This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Treatment of chlamydia in pregnancy

Authoring team

Chlamydia infection should be managed at a specialist genitourinary medicine (GUM) clinic. The GUM clinic will be able to screen for further sexually transmitted diseases and undertake contact tracing.

Chlamydia treatment if pregnant/breastfeeding in adult:

  • azithromycin 1g stat for one day; then 500mg once daily for two days (total course 3 days)

Key points:

  • opportunistically screen all sexually active patients aged 15 to 24 years for chlamydia annually and on change of sexual partner
  • if positive, treat index case, refer to GUM and initiate partner notification, testing and treatment
  • advise patient with chlamydia to abstain from sexual intercourse for 7 days after treatment with azithromycin (14 days after azithromycin started and until symptoms resolved if urethritis)
  • if chlamydia, test for reinfection at 3 to 6 months following treatment if under 25 years; or consider if over 25 years and high risk of re-infection
  • as lower cure rate in pregnancy, test for cure at least 3 weeks after end of treatment.
  • consider referring all patients with symptomatic urethritis to GUM as testing should include Mycoplasma genitalium and Gonorrhoea.

Reference:


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.